Premium
Homegrown private equity firm ChrysCapital has emerged as the primary suitor to clinch an investment in a Mumbai-based drug maker,......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
